Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 1, 2011

Primary Completion Date

May 1, 2015

Study Completion Date

May 31, 2015

Conditions
Hepatitis C
Interventions
BEHAVIORAL

intervention group

The investigators will use a variety of learning techniques, including lecture, brainstorming, small and large group activity, individual worksheets, role-play, and video player. For example, small teams of up to 5 participants will conduct role-plays; large groups also will be assembled to encourage talking about HCV-related risk reduction behavior.

BEHAVIORAL

control group

The investigators will adopt previous treatment in the clinics to intervent the patients

Trial Locations (2)

Unknown

Shanghai Hong Kou MMT clinic, Shanghai

Shanghai Yang Pu MMT clinic, Shanghai

All Listed Sponsors
lead

Shanghai Mental Health Center

OTHER

NCT01647191 - Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China | Biotech Hunter | Biotech Hunter